Publication | Open Access

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

Metabolic SyndromeHepatologyBiochemistryAmp-activated Protein KinaseLiver PhysiologyMedicinePathologyMetabolic RegulationLiver DiseaseFatty Liver DiseaseMetabolomicsMetabolismPharmacologyLipid SynthesisOxidative StressHealth Sciences